JPMorgan Hikes IREN Target to $46, Stays Underweight
JPMorgan raises its IREN price target to $46 but preserves an underweight stance, citing structural risk in NVIDIA’s ...
Stock picking requires research and discipline; assess whether your time, resources, and goals justify active selection over passive options.
17,093 articlesJPMorgan raises its IREN price target to $46 but preserves an underweight stance, citing structural risk in NVIDIA’s ...
Chip stocks pause after a blistering run, with Intel crashing 10%, slides as investors take profits and reassess AI m...
Analysts on Thursday issued fresh calls across a raft of names, from Commercial Metals to Wix.com, signaling continue...
As Mink (INKT) closes 2025, investors want clarity on growth, margins, and cash generation. This analysis breaks down...
Intel faces a pivotal moment as Q1 losses mount and cash burn deepens. Analysts and investors debate buy, hold sell i...
Meta Platforms delivered a powerful Q1 2026, with revenue surging and AI investment plans outlined, prompting investo...
SpaceX’s IPO filing reveals Elon Musk’s proposed package, a historic grant that vests only if the company reaches a $...
Private markets are tightening their grip on everyday investing. This article explains how the line between public an...
A big strategic shift from Lilly could redefine how investors view weight-loss drugs. This article breaks down what h...
Discover FitLife's 2025 earnings story, from revenue drivers to margins and cash flow. This guide breaks down what th...
NVIDIA sits atop market caps, but size isn’t the same as influence. This article breaks down what 'largest' means, wh...
Analysts weigh whether Credo can reach $350 by 2028 as AI infrastructure spending stays strong and the company accele...